Teton Advisors Inc. Acquires New Shares in ZimVie Inc. (NASDAQ:ZIMV)

Teton Advisors Inc. bought a new position in ZimVie Inc. (NASDAQ:ZIMV) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 15,000 shares of the company’s stock, valued at approximately $266,000. Teton Advisors Inc. owned approximately 0.06% of ZimVie at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of ZIMV. First Eagle Investment Management LLC grew its stake in shares of ZimVie by 73.1% in the fourth quarter. First Eagle Investment Management LLC now owns 294,673 shares of the company’s stock worth $5,230,000 after acquiring an additional 124,487 shares during the period. Boston Partners purchased a new stake in ZimVie in the fourth quarter worth approximately $310,000. Charles Schwab Investment Management Inc. grew its position in ZimVie by 21.1% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 761,285 shares of the company’s stock worth $13,513,000 after purchasing an additional 132,804 shares during the period. Russell Investments Group Ltd. raised its stake in ZimVie by 60.4% during the 4th quarter. Russell Investments Group Ltd. now owns 279,413 shares of the company’s stock valued at $4,960,000 after buying an additional 105,256 shares during the last quarter. Finally, Bailard Inc. bought a new position in shares of ZimVie during the 4th quarter valued at $254,000. Hedge funds and other institutional investors own 95.63% of the company’s stock.

ZimVie Price Performance

Shares of NASDAQ:ZIMV traded up $0.33 during trading on Thursday, hitting $15.83. 146,364 shares of the company’s stock were exchanged, compared to its average volume of 340,427. The company has a debt-to-equity ratio of 1.26, a current ratio of 2.78 and a quick ratio of 2.32. ZimVie Inc. has a 52-week low of $6.52 and a 52-week high of $20.91. The business’s 50-day simple moving average is $16.78 and its 200 day simple moving average is $14.73. The company has a market cap of $430.89 million, a price-to-earnings ratio of -1.05 and a beta of 2.17.

ZimVie (NASDAQ:ZIMV) last released its earnings results on Wednesday, February 28th. The company reported $0.10 earnings per share (EPS) for the quarter. ZimVie had a positive return on equity of 2.44% and a negative net margin of 51.33%. The firm had revenue of $113.07 million during the quarter.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on ZIMV. Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research report on Thursday, April 11th. Barclays upped their price target on ZimVie from $13.00 to $16.00 and gave the stock an “underweight” rating in a research report on Tuesday, March 5th.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.